23/01/2025  21:00:02 Var. 0.000 Volume Denaro23/01/2025 Lettera23/01/2025 Capitalizzazione di mercato Dividend Y. Rapporto P/E
68.900EUR 0.00% -
Fatturato: -
68.900Quantità in denaro: 51 69.500Quantità in lettera: 50 1.19 bill.EUR 0.31% 49.42

Descrizione business

NEXUS AG is one of Europe's leading software providers in the healthcare sector. The company's software solutions support customers in the procurement of information and medical documentation in particular. In product development, the focus is on simple and fast application by the user. In addition to integrated complete solutions, NEXUS also works as a solution provider for healthcare IT. The company offers solutions for all requirements of healthcare facilities for modern software systems: from patient management, specialist medical solutions with all billing modalities to quality and organizational management. With its IT services, NEXUS offers a further combination of system integration, operation and support for various applications.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Ingo Behrendt
Consiglio di amministrazione
Edgar Kuner, Ralf Heilig
Consiglio di sorveglianza
Dr. Hans-Joachim König, Dr. Dietmar Kubis, Prof. Dr. Felicia Mechtild Rosenthal, Rolf Wöhrle, Florian Herger, Juergen Rottler
 

Dati aziendali

Name: NEXUS AG
Indirizzo: Irmastraße 1,D-78166 Donaueschingen
Telefono: +49-771-22960-0
Fax: +49-771-22960-999
E-mail: info@nexus-ag.de
Internet: de.nexus-ag.de
Industria: Technology
Settore: IT-Services
Sub settore: IT Consulting & Services
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: 24/07/2000

Rapporti con gli investitori

Name: -
IR telefono: -
IR Fax: -
IR e-mail: ir@nexus-ag.de

Company calendar

CW 10 | 04/03/2025 4th Quarter/Annual Report
CW 21 | 20/05/2025 Interim Report 1st Quarter/3 Months
CW 21 | 22/05/2025 General Shareholder Meeting
CW 33 | 12/08/2025 Interim Report 2nd Quarter/6 Months
CW 45 | 04/11/2025 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
61.18%
Luxempart
 
10.06%
Brown Capital Management LLC
 
9.18%
FMR LLC
 
9.11%
GUB Venture Capital GmbH & Co. KG aA
 
5.96%
Allianz Global Investors
 
4.51%